Αποτελέσματα Αναζήτησης
Younger age (40-49 years, OR = 8.14 [1.35-49.13]) and nonsmoking (OR = 5.39 [1.48-19.65]) predicted recovery from HLH. Men with iHLH developed erectile dysfunction, poor health, cardiovascular disease (CVD) and cancer more frequently than pNLH men.
High levels of LH in men can indicate so-called primary testicular failure, which can be due to defects in the development of the testes or to illness (e.g. adult mumps), injury, for example during sport, or due to treatment for cancer in the form of chemotherapy or radiation therapy.
23 Νοε 2023 · Diagnosing imbalances in Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) is a critical step in addressing the complex issues related to male hormonal health. The process involves a combination of clinical assessments, detailed medical histories, and specific laboratory tests.
LoH may be better reserved for older men with otherwise unexplained primary gonadal insufficiency. Although the incidence of primary hypogonadism in men is low (0.2%/year), it increases with both age and
27 Νοε 2017 · Elevated luteinizing hormone (LH) with normal testosterone (T) suggests compensated dysregulation of the gonadal axis. We describe the natural history, risk factors and clinical parameters associated with the development of high LH (HLH, LH >9.4 U/L) in ageing men with normal T (T ≥ 10.5 nmol/L).
Elevated LH and FSH values indicate primary (testicular) hypogonadism, whereas low or importantly even inappropriately ‘normal’ LH and FSH values may indicate secondary (pituitary–hypothalamic) hypogonadism.
In patients with signs and symptoms indicative of hypogonadism, determining luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels together with the initial testosterone level is usually most efficient.
